GENE ONLINE|News &
Opinion
Blog

2022-09-16| COVID-19Special

The COVID-19 Pandemic: Is Omicron the Last Variant?

by Max Heirich
Share To
The COVID-19 pandemic saw the rise of multiple strains that put the companies manufacturing vaccines through their paces to keep up. With the FDA approving new vaccines for the latest substrains of the Omicron Variant, it seems that COVID-19 Cases are finally slowing down. These Emergency Use Authorizations were pushed through in a manner of days, marking them as some of the fastest ever in FDA history. However, they were based upon mountains of prior research done on their predecessors for prior strains as well as the heavily mutated Omicron Strains.
How do these vaccines function differently from their prior counterparts? And will these boosters bring about the end of the COVID-19 pandemic after so many strain mutations?

GO Prime with only $1.49 now

LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!